Brief: Pharming Group Launches About EUR 100 Mln Bonds Offering

Pharming

18/04/2024 07:05

April 18 (Reuters) - Pharming Group NV  PHAR.AS :
    * PHARMING GROUP ANNOUNCES THE LAUNCH OF AN OFFERING OF
APPROXIMATELY €100 MILLION CONVERTIBLE BONDS DUE 2029 AND THE
CONCURRENT REPURCHASE OF THE OUTSTANDING €125 MILLION
CONVERTIBLE BONDS DUE 2025
    * NEW BONDS ARE EXPECTED TO BE ISSUED ON 25TH APRIL 2024 AND
TO
CARRY A COUPON OF 4.50% PER ANNUM PAYABLE SEMI-ANNUALLY
    * NEW BONDS WILL HAVE A MATURITY DATE OF 25TH APRIL 2029
    * INITIAL CONVERSION PRICE AT WHICH NEW BONDS MAY BE
CONVERTED
INTO SHARES EXPECTED TO BE SET AT A PREMIUM OF BETWEEN 32.50%
AND 42.50%
    * WILL USE PROCEEDS FROM OFFERING FOR CONCURRENT REPURCHASE
OF
2025 BONDS

Source text for Eikon:  ID:nGNE5zMf0k 
Further company coverage:  PHAR.AS 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))